Category Archives: Patently BIOtech

Secretary Sebelius delivered a speech in California yesterday which recognized the potential of biotechnology to address unmet needs in human health, agriculture and industrial and environmental applications. In her remarks, Secretary Sebelius stated: “[I]nvesting in each step of the process that starts with basic scientific discovery and ends with the development and provision of better diagnostics, treatments, and preventive strategies to significantly improve health care. I know I don’t have to tell you that because Read More >

An article about BIO’s recent Technology Transfer Symposium. Getting to Market: The Challenges of Technology Transfer Attendees at special symposium focus on issues of commercializing and licensing biotech discoveries Read the post on BIOtech NOW

Patently Biotech has a new writer. My name is Roy Zwahlen and I am the new Intellectual Property manager at BIO. I am an attorney and political science undergraduate and fascinated with intellectual property policy. I am excited about this opportunity to enter the IP blogosphere. My hope is to provide information about BIO’s IP activities including conferences and amicus briefs. I also hope to reintroduce our IP staff and spotlight our BIO company members. Read More >

The BIO-AUTM Technology Transfer Symposium panel on The Role of Universities, Biotechnology Companies and Technology Transfer in the Innovation Economy included an active debate on issues ranging from increasing the odds for a successful partnership and the pros and cons of the Bayh-Dole Act.